Combining nonexchangeable functional or survival data sources in
  oncology using generalized mixture commensurate priors by Murray, Thomas A. et al.
ar
X
iv
:1
51
1.
05
36
7v
1 
 [s
tat
.A
P]
  1
7 N
ov
 20
15
The Annals of Applied Statistics
2015, Vol. 9, No. 3, 1549–1570
DOI: 10.1214/15-AOAS840
c© Institute of Mathematical Statistics, 2015
COMBINING NONEXCHANGEABLE FUNCTIONAL OR SURVIVAL
DATA SOURCES IN ONCOLOGY USING GENERALIZED
MIXTURE COMMENSURATE PRIORS
By Thomas A. Murray∗,1, Brian P. Hobbs∗,1,2 and
Bradley P. Carlin†,1
University of Texas MD Anderson Cancer Center∗ and
University of Minnesota†
Conventional approaches to statistical inference preclude struc-
tures that facilitate incorporation of supplemental information ac-
quired from similar circumstances. For example, the analysis of data
obtained using perfusion computed tomography to characterize func-
tional imaging biomarkers in cancerous regions of the liver can ben-
efit from partially informative data collected concurrently in non-
cancerous regions. This paper presents a hierarchical model struc-
ture that leverages all available information about a curve, using
penalized splines, while accommodating important between-source
features. Our proposed methods flexibly borrow strength from the
supplemental data to a degree that reflects the commensurability of
the supplemental curve with the primary curve. We investigate our
method’s properties for nonparametric regression via simulation, and
apply it to a set of liver cancer data. We also apply our method for a
semiparametric hazard model to data from a clinical trial that com-
pares time to disease progression for three colorectal cancer treat-
ments, while supplementing inference with information from a previ-
ous trial that tested the current standard of care.
1. Introduction. Statistical investigations begin by determining which
sources(s) of information will be used to answer the motivating questions
and generate hypotheses for future exploration. Conventional approaches
to statistical inference preclude structures that facilitate incorporation of
partially informative data, imposing polarity on the data selection process.
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Putatively relevant supplemental data acquired from broadly similar ther-
apeutic interventions, patient cohorts, previous investigations or biological
processes are often either excluded from statistical analysis or treated as
exchangeable with the primary data. In oncology, prospective studies de-
signed to evaluate the performance of an experimental therapy usually ig-
nore historical information about the control therapy and limit enrollment
to patients presenting lesions with a particular histological subtype, grade
or performance status, or who are na¨ıve to prior therapy. In contrast, stud-
ies with more liberal information inclusion rules, such as intention-to-treat
designs, often pool information from potentially heterogeneous sources or
adjust for this potential heterogeneity using simple linear regressors.
Ignoring relevant, supplemental sources of information reduces the repro-
ducibility and scope of the primary study. On the other hand, using the sup-
plemental information while neglecting to account for heterogeneity between
the sources of information obscures understanding of the complex underly-
ing mechanisms that produced the primary data and may lead to severely
biased inference. Relaxing this dichotomy would improve the efficiency of
the experimental process and enable investigators to implement statistical
models that use all available information while accommodating important
between-source features. Several models have been proposed for incorporat-
ing partially informative supplemental data. Pocock (1976) used generalized
linear models with static, data-independent borrowing using a prespecified
amount of between-source variability. Ibrahim and Chen (2000) proposed
data-independent or dynamic nonhierarchical methods for partially weight-
ing likelihoods. Bayesian [Smith, Spiegelhalter and Thomas (1995)] and fre-
quentist [Doi, Barendregt and Mozurkewich (2011)] methods using hierar-
chical modeling have been developed for estimating between-source variabil-
ity for univariate observables or repeated measures with generalized linear
relations among covariates.
Bayesian hierarchical models facilitate dynamic partial pooling of between-
source information and flexibly estimate the extent of borrowing. Here the
goal is limiting bias for estimating primary effects when between-source het-
erogeneity occurs, while improving efficiency when approximate coherence,
or commensurability, occurs; see Hobbs, Sargent and Carlin (2012) for gen-
eralized linear mixed models, and Hobbs, Carlin and Sargent (2013) and
Murray et al. (2014) for piecewise-exponential time-to-event models. In Sec-
tion 2 we discuss these methods, which can be used to borrow strength from
supplemental data in parametric models for regression coefficients and other
univariate parameters. We then develop a Bayesian hierarchical model struc-
ture to leverage supplemental information more generally, including for both
nonparametric regression and semiparametric hazard models with penalized
splines. The literature appears devoid of general methods for flexibly bor-
rowing strength from supplemental data in semi- and nonparametric models
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for a group of related parameters that characterize a complex object (e.g.,
a curve or surface).
Two oncological applications motivate our methodological developments.
The first, from diagnostic radiology, involves estimating prognostic func-
tional imaging biomarkers acquired using perfusion computed tomography
(CT) in cancerous and cancer-free liver tissue. Perfusion CT is an emerg-
ing technology that enables observation and quantification of characteristics
pertaining to the passage of fluid through blood vessels. Researchers have
developed physiological models to quantify a variety of perfusion character-
istics derived from analysis of the distribution of contrast enhancement in
tissue acquired using repeated CT scans during intravenous administration
of contrast medium. Investigators have used the technology in a number of
organs and tumors, including prostate, colorectal, head and neck, lung and
liver. Miles and Griffiths (2003) review the clinical relevance of perfusion
CT.
Our application considers three characteristics: permeability-surface area
product (PS), blood volume (BV), and blood flow (BF). Each characteristic
is measured at 7 to 13 acquisition times between 11 and 95 seconds following
contrast injection. Data from 16 individuals comprise a total of 25 regions
containing pathology-verified metastases to the liver from neuroendocrine
tumors (i.e., cancerous liver tissue), and a total of 27 regions consisting of
noncancerous liver tissue. PS and BF are rates measured as milliliters per
minute per 100 grams of liver tissue (ml/min per 100 g), whereas BV is a
volume measured as milliliters per 100 grams of liver tissue (ml per 100 g).
Figure 1 displays the observed perfusion CT (CTp) curves along with Loess
estimates of the average CTp curve for each characteristic in each tissue
region. Characterization of the perfusion characteristics in cancerous tissue
has implications for constructing biomarkers to assist in treatment moni-
toring, prognostication and pathophysiological understanding of metastatic
tumor vasculature. It is important that the acquisition duration cover the
range of CTp curve instability, but once the curve has stabilized, the scan
can be terminated. To limit radiation exposure and cost, the acquisition du-
ration should be minimized [Ng et al. (2013)]. Critically, because the tissue
type is unknown prior to diagnosis, any proposed acquisition period must
ensure stable quantification of CTp characteristics for both types of tissue
before CTp can be used for detection of metastatic sites. Though nonex-
changeable, the perfusion CT data obtained in cancer-free liver tissue may
inform the shape and stabilization time of the corresponding CTp curve in
cancerous tissue. Figure 1 shows substantial heterogeneity in the shapes of
the average CTp curves by tissue region for PS, whereas for BV and BF,
the average CTp curves are more similar.
Our second application, from colorectal cancer, involves estimating prog-
ression-free survival (PFS) with data from two consecutive randomized phase
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Fig. 1. Individual-by-region perfusion CT (CTp) curves are displayed by tissue region
(“Individual CTp curves”) for permeability-surface area product (PS), blood volume (BV)
and blood flow (BF), over acquisition durations between 11 and 95 seconds after contrast
injection. The dots mark actual observations. The thick “Average CTp curve” is a Loess
estimate that ignores potential clustering.
III colorectal cancer trials, reported by Saltz et al. (2000) and Goldberg et al.
(2004). Both trials used PFS to assess the efficacy of various treatment reg-
imens for patients with previously untreated metastatic colorectal cancer;
disease progression was defined as a 25% increase in measurable tumor size,
presence of a new lesion or death. The initial trial [Saltz et al. (2000)] com-
pared three treatment regimens: 5-Fluorouracil and Leucovorin, Irinotecan
alone, and Irinotecan and bolus Fluorouracil plus Leucovorin (IFL). The re-
sults indicated that the IFL regimen was significantly more efficacious than
the other two regimens, and IFL became the “standard of care” leading
into the subsequent trial [Goldberg et al. (2004)], which then compared an
identical IFL regimen with two novel regimens: Oxaliplatin with infused
Fluorouracil plus Leucovorin (FOLFOX), and Irinotecan with Oxaliplatin
(IROX).
Figure 2 shows that the PFS curves for the IFL regime are commensurate
in the Saltz and Goldberg trials, with the PFS curve in the Goldberg trial
tracking just above that of the Saltz trial, though within the 95% CIs for
nearly all of follow-up. Moreover, Figure 2 suggests that in the Goldberg
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Fig. 2. Kaplan–Meier estimates of PFS for the IFL regimen in the Saltz trial (along
with 95% CIs), and the IFL, FOLFOX and IROX regimes in the Goldberg trial.
trial FOLFOX is superior to both IROX (log-rank test p-value of 0.006)
and IFL (log-rank test p-value < 0.001), and that IFL and IROX perform
similarly (log-rank test p-value of 0.404). The efficiency for estimating the
PFS curve of the IFL regimen in the Goldberg trial may be improved by
using nonexchangeable, yet relevant data on the IFL regimen in the Saltz
trial.
The commonality between our two motivating examples is the availabil-
ity of supplemental information about unknown curves that may aid our
inference in the primary investigation (i.e., CTp curves among tissue types,
and PFS curves of IFL among clinical trials). In Section 3 we investigate
the borrowing properties via simulation of the proposed hierarchical model
structure for nonparametric regression using penalized splines, and then we
analyze the perfusion CT data. In Section 4 we analyze data from the col-
orectal cancer clinical trials using the proposed hierarchical structure for a
semiparametric hazard model. In Section 5 we close with a discussion and
propose directions for future work.
2. Leveraging supplemental information. We restrict our attention to
two Bayesian methods for leveraging supplemental information, power priors
[Ibrahim and Chen (2000)] and commensurate priors [Hobbs et al. (2011)].
In general, Bayesian models consist of a likelihood for the data and prior
specifications for the parameters in the likelihood [see, e.g., Carlin and Louis
(2009)]. For both these modeling approaches, the primary and supplemental
likelihoods are assumed to have the same structure (e.g., both Gaussian),
and we denote them by L(θ|D) and L(θ0|D0), respectively. As a result, the
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supplemental parameter θ0 is analogous to the primary parameter θ, and
information about θ0 can be leveraged to aid posterior inference about θ.
2.1. Existing methods. Power priors assume the sources of information
are exchangeable (i.e., θ ≡ θ0) and downweight the supplemental likelihood
by raising it to a prespecified power a0 ∈ [0,1]. This strategy works because
raising the supplemental likelihood to the power a0 diffuses it. In the ex-
treme case where a0 = 0, the downweighted supplemental likelihood is a
noninformative constant. Formally, the posterior arises as
p(θ|D,D0)∝L(θ|D)L(θ|D0)
a0π(θ).(1)
Alternatively, a0 can be modeled as another unknown parameter in the
model [Ibrahim and Chen (2000)]. Power priors are extremely general, so
nothing explicitly prevents their use in any modeling context. However,
they employ a single parameter (a0) to control between-source borrowing,
thereby making differential borrowing among components of θ infeasible
unless L(θ|D) has a convenient factorization, as it generally does not. This
is undesirable because the supplemental data may provide relevant infor-
mation for only a subset of θ. Furthermore, when a0 is assumed unknown,
power priors tend to excessively downweight the supplemental likelihood,
even when D0 and D are identical [Neelon and O’Malley (2010)].
Commensurate priors do not assume the sources of information are ex-
changeable (i.e., θ 6≡ θ0), and instead specify a hierarchical model where the
posterior arises as
p(θ,θ0,η|D,D0)∝ L(θ|D)L(θ0|D0)π(θ|θ0,η)π(η)π(θ0).(2)
The commensurate prior, π(θ|θ0,η), “centers” θ about θ0, and η con-
trols between-source borrowing to reflect the commensurability of the two
parameters. In practice, π(θ|θ0,η) is defined so that E[θ|θ0,η] = θ0 and
Var[θ|θ0,η] is decreasing in η.
For a unidimensional real-valued parameter θ, a useful approach takes
θ|θ0, η ∼N (θ0, η
−1), a Gaussian distribution with mean θ0 and precision η.
Estimation of η is inherently difficult, but feasible by inducing sparsity over
the precision domain using a “spike-and-slab” prior for η [Hobbs, Sargent
and Carlin (2012)]. The spike-and-slab prior has a mixture density
π(η)≡ (1− p0)U(η|sl, su) + p0δR(η),(3)
where 0 ≤ sl < su << R and p0 ∈ [0,1] are prespecified, and δR(η) is one
at R and zero otherwise. The distribution in (3) is locally uniform on the
“slab,” (sl, su), with probability (1− p0), and places probability mass p0 at
the “spike,” R, otherwise.
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We prefer to modify the commensurate prior construction suggested by
Hobbs, Sargent and Carlin (2012) as
θ|θ0, τ, ι∼ [N (θ0, τ
−1)](1−ι)[N (θ0,R
−1)]ι,
(4)
ι∼ Bern(p0) and τ ∼ U(sl, su),
where Bern(p0) denotes a Bernoulli distribution with Pr(ι= 1) = p0. There-
fore, the commensurate prior in (3) induces a two-part mixture prior distri-
bution on θ that consists of a highly concentrated component [i.e.,
N (θ0,R
−1)] and a relatively diffuse component [i.e., N (θ0, τ
−1)], both cen-
tered at θ0. The model in (4) has parallels to Bayesian variable selection
methods, in which the two-part mixture prior for a regression coefficient
has one component heavily concentrated about zero and the other vague
[see, e.g., George and McCulloch (1997)]. Hence, the commensurate prior
facilitates selective borrowing by inheriting the selective shrinkage property
of the spike-and-slab distributions used in Bayesian variable selection. In
particular, the commensurate prior strongly shrinks θ to θ0 when evidence
indicates that this difference is small, thereby improving efficiency, and min-
imally affects θ otherwise, thereby limiting bias.
We specify the spike so that if θ|θ0 ∼ N (θ0,R
−1), θ deviates negligibly
from θ0. On the other hand, we specify the slab to contain small values
that correspond to modest shrinkage of θ toward θ0. Hence, a N (θ0, s
−1
u )
prior for θ will be weakly informative. The tails of the prior distribution
in (4) are jointly controlled by sl and su: when sl ≈ 0, smaller values of su
provide a prior with heavier tails. In our experience, posterior inference on
θ is insensitive to modest shifts in these hyperparameters, so we suggest
specifying sl near zero, with su small and R large relative to the magnitude
of a meaningful difference between θ and θ0. Posterior inference can be
sensitive to the fourth hyperparameter, p0, the prior probability of effective
equality between θ and θ0. We recommend choosing the value for p0 to
deliver satisfactory operating characteristics at the anticipated sample size,
such as mean-squared-error properties over a range of likely true differences
between θ and θ0; see Murray et al. (2014).
Specifying a value for su that is too large can result in a model that
is not robust to between-source heterogeneity, whereas specifying a value
for R that is too small will result in a model that gains little posterior
precision for θ even when D0 and D are equivalent. Specifying too small a
value for p0 may also result in a model that borrows little when D0 ≡D,
whereas specifying too large a value for p0 may result in a model that borrows
too much (resulting in unacceptable bias) in the presence of substantial
between-source heterogeneity. Of course, p0’s influence on posterior inference
diminishes as the primary sample size increases.
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2.2. Generalized mixture commensurate priors. The general model struc-
ture described in (2) can accommodate a latent precision parameter (com-
ponent of η) for each component of θ. Therefore, the extent to which the
supplemental data influence estimation of the primary effects can be allowed
to differ among the components of θ, yielding flexibility and reducing bias.
However, assuming mutual independence between the components of η al-
lows strength to be borrowed from the supplemental source(s) differentially
among the components of θ, reducing efficiency. Though this may be sensi-
ble, differential borrowing among the components of θ may not always be
appropriate.
Suppose β = (β1, . . . , βK) is a subset of θ that characterizes a feature in
the primary data (e.g., the shape of a CTp curve), with an analogous defi-
nition for β0. We may wish to borrow from the supplemental data for β0 to
a degree that reflects its coherence with β in its entirety, rather than case-
by-case for each βk. Moreover, β (and β0) may conventionally be assigned a
prior that induces smoothness. Ideally, (2) will inherit the smoothness prop-
erties of the conventional prior and simultaneously borrow similar amounts
for related subgroups of θ (i.e., β). We propose to model
βk|ιk, βk,0 ∼ [π
∗(βk|βk,0)]
1−ιk [π(βk|βk,0)]
ιk ,
(5)
ιk|ν ∼ Bern(ν), ν ∼B(a1, a2), β0,k ∼ π
∗(β0,k),
where B(a1, a2) denotes a beta distribution with mean
a1
a1+a2
and the spec-
ifications for π∗ mirror a conventional analysis of these data. To facilitate
borrowing of strength, we take π(βk|β0,k) in (5) to be heavily concentrated
about β0,k; we provide exact specifications for each application later. To bor-
row similar amounts of strength for each component of β, we assume the ιk
are identically distributed with Pr(ιk = 1) = ν. Thus, the resulting prior is
composed of K two-piece mixtures and generalizes the commensurate prior
defined in (4). Hereafter, we refer to the general prior structure defined in
(5) as a generalized mixture commensurate (GMC) prior.
3. GMC priors in nonparametric regression analysis. Suppose y= (y1,
. . . , yN ) is a real-valued variable (e.g., log blood flow, as in Figure 1) that
depends on a continuous covariate t= (t1, . . . , tN ) (e.g., time, as in Figure 1),
and that we model yi ∼N (φ(ti), σ
2). Often primary interest lies in the shape,
derivatives or some other function of φ, and φ requires a smooth but flexible
nonparametric specification, as opposed to a parametric linear specification
φ(t) = β0 + β1t. Penalized splines are a practical choice for modeling φ; see
Ruppert, Wand and Carroll (2003), Chapters 3 and 14. There are many
ways to formulate a penalized spline. Low-rank thin-plate (LRTP) splines
are appealing since they are defined by tractable radial basis functions and
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tend to exhibit fast Markov chain Monte Carlo (MCMC) convergence prop-
erties in a Bayesian context relative to truncated basis splines [Crainiceanu,
Ruppert and Wand (2005)]. B-splines are another reasonable Bayesian op-
tion because they too tend to exhibit fast MCMC convergence, but they
rely on a recursive algorithm to define the basis functions, making them
less tractable than LRTP splines [Eilers and Marx (1996)]. Our method will
work with either LRTP or B-spline formulations for φ, and we do not an-
ticipate substantial differences in the behavior of our method under either
formulation. Hereafter, we focus on a LRTP cubic spline specification for φ.
Without loss of generality, we take t ∈ [0,1] and model
φ(t;β) = β0 + β1t+
K∑
k=2
βk(|t− t˜k−1|
3 − |t˜k−1|
3),(6)
where t˜ = (0 = t˜0 < t˜1 < · · ·< t˜K−1 < t˜K = 1) is a generic partition with K
intervals. We discuss this choice later. Typically, a LRTP spline model is
formulated as
φ(t;β∗) = β∗0 + β
∗
1t+
K∑
k=2
β∗k |t− t˜k−1|
3;(7)
however, in (7), β∗0 is not an intercept because φ(0;β
∗) = β∗0+
∑K
k=2 β
∗
k |t˜k−1|
3.
We prefer the modified LRTP (mLRTP) model defined in (6), because it
simplifies interpretation and prior elicitation when the regression includes
an intercept, which will be the case for the CTp data, and it retains an
equivalent interpretation of (β1, . . . , βK) and (β
∗
1 , . . . , β
∗
K). In the sequel, we
denote β(−0) = (β1, . . . , βK), that is, the vector β with β0 omitted.
A penalized spline requires prespecification of a fine partition t˜, and
smooths via the prior, whereas a free-knot spline uses complex sampling
algorithms (e.g., reversible-jump MCMC) to sample over all possible par-
titions. We prefer penalized splines, since they are computationally much
simpler and have proven to be competitive with free-knot splines when the
temporal variation of φ is smooth [Ruppert, Wand and Carroll (2003), Sec-
tion 3.16]. Wand (2000) reviews methods for free-knot spline estimation; we
do not consider this approach further. To select t˜ for a penalized spline, we
consider a set of values for K with either equally-spaced or quantile-spaced
t˜k’s, and select the partition that has low posterior mean deviance and de-
viance information criterion (DIC) relative to the other partitions considered
[Spiegelhalter et al. (2002)].
Following Crainiceanu, Ruppert and Wand (2005), without supplemental
data, we complete the Bayesian specification of (6) by placing vague priors on
β0 and β1, and a N (0, σ
2
βΩ
−) prior on (β2, . . . , βK)
′, where the (j, k)th entry
of Ω is defined as |t˜j−1 − t˜k−1|
3, for j, k = 2, . . . ,K. In practice, we apply
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the transformations b0 = β0, b1 = β1, (b2, . . . , bK)
′ =Ω1/2(β2, . . . , βK)
′, and
σ2
b
= σ2β , and then complete the model specification by assuming
π∗(bk)≡N (bk|0,10
4) for k = 0,1,
π∗(bk|σb)≡N (bk|0, σ
2
b) for k = 2, . . . ,K and(8)
π∗(σb)≡ U(σb|0.01,100).
The prior in (8) smooths φ by preferring values for (b2, . . . , bK) near zero a
priori.
3.1. GMC prior specification. With supplemental data [y0 = (y0,1, . . . ,
y0,n0), t0 = (t0,1, . . . , t0,n0)], we also assume y0,i0 |t0,i0 ∼N (φ0(t0,i0), σ
2
0), for
i0 = 1, . . . , n0. To ensure that φ and φ0 are analogous, we use the same
partition t˜ for φ0, and model φ0(t;β0) using (6) by replacing β with β0.
We apply the transformation b0,k = β0,k, for k = 0,1, and (b0,2, . . . , b0,K)
′ =
Ω1/2(β0,2, . . . , β0,K)
′, and use the prior specifications π∗(b0,k)≡N (b0,k|0,10
4),
for k = 0,1, π∗(b0,k|σb0) ≡ N (b0,k|0, σ
2
b0
) for k = 2, . . . ,K, and π∗(σb0) ≡
U(σb0 |0.01,100).
To borrow flexibly for the shape of φ from the supplemental data for φ0,
we apply the GMC prior specification defined in (5) to b(−0) = (b1, . . . , bK)
given b0,(−0) = (b0,1, . . . , b0,K). We assume
π(b(−0)|b0,(−0), ι(−0), σb)
= [π∗(b1)]
(1−ι1)[π(b1|b0,1)]
ι1
K∏
k=2
[π∗(bk|σb)]
(1−ιk)[π(bk|b0,k)]
ιk ,
where ι(−0) = (ι1, . . . , ιK), and π
∗(b1), π
∗(bk|σb) and π
∗(σb) are defined in
(8). We set π(bk|b0,k) ≡ N (bk|b0,k,R
−1
b
), for k = 1, . . . ,K, where Rb is a
prespecified large value. We then specify ιk|ν
iid
∼ Bern(ν) and ν ∼ B(a1, a2)
with fixed, known hyperparameters a1 and a2 that reflect our prior opinion
about the relevance of the supplemental data for the shape of φ.
To allow differential borrowing for the intercept versus the shape of φ, we
specify an independent commensurate prior distribution for b0 given b0,0
following (4). We define π(b0|b0,0, ι0, τ) ≡ [π
∗(b0|b0,0, τ)]
(1−ι0)[π(b0|b0,0)]
ι0 ,
where π∗(b0|b0,0, τ) ≡ N (b0|b0,0, τ
−1) and π(b0|b0,0) ≡ N (b0|b0,0,R
−1). We
then specify τ ∼ U(sl, su) and ι0 ∼ Bern(p0), where sl, su, R and p0 are
prespecified following the guidance in Section 2. Taken together, the full
posterior arises as
p(b,b0, σb, σb0 , ι, ν, τ |D,D0)
∝ L(b|D)L(b0|D0)π(b0|b0,0, ι0, τ)π(ι0)π(τ)π
∗(b0,0)
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(9)
× π(b(−0)|b0,(−0), ι(−0), σb)π(ι(−0)|ν)π(ν)π
∗(σb)
× π∗(b0,(−0)|σb0)π
∗(σb0).
3.2. Simulation assessment. We now investigate via simulation the bor-
rowing properties of the GMC prior model in (9) for nonparametric regres-
sion. To do so, we sample yi|ti ∼ N{µ(ti), σ
2}, i = 1, . . . ,N , where µ(t) =
5t sin{5t}, and sample y0,i0 |t0,i0 , d∼N{µ0(t0,i0 |d), σ
2
0}, i0 = 1, . . . ,N0, where
µ0(t|d) = (5+d)t sin((5+d)t) and d ∈ [0,5]. Hence, the primary data always
have the same true mean structure, and the supplemental data have a mean
structure that deviates from that of the primary according to the value of d,
the discordance parameter. When d= 0, the two curves are the same, and as
d increases, the supplemental curve has increasingly greater curvature than
the primary curve. Figure 3 shows curves for selected values of d.
In each run, we sample d uniformly from the set {0, 0.05, 0.10, 0.20,
0.35, 0.50, 0.75, 1, 1.50, 2, 3, 4, 5}. Given d, we then generate primary
and supplemental data sets with N =N0 = 50, error variances σ
2 = σ20 = 1,
and equally spaced t and t0 values over [0,1]. For each data set pair, (D=
(y, t),D0 = (y0, t0)), we fit the GMC prior model developed in Section 3.1.
We use the mLRTP model defined in (6) with K = 10 and t˜ spaced equally
over [0,1] for both φ0(t0;β0) and φ(t;β). After preliminary investigation,
we set sl = 0, su = 2, R= 2000, p0 = 0.50, and π(ν)≡ B(ν|0.50,0.50). The
latter two choices represent an indifferent prior opinion about the relevance
of the supplemental data for both the shape and the intercept of φ. We
choose to place an extremely vague yet indifferent prior on ν to allow the
primary and supplemental data to have substantial influence on whether to
borrow for curve shape.
We used the R2jags package to call JAGS from R, and ran two chains
for 20,000 iterations of burn-in, followed by 200,000 iterations for posterior
estimation. We also fit the mLRTP model defined in (6) with prior specifi-
cations described in (8) to the primary data alone, as well as to the data set
obtained by simply pooling the primary and supplemental data. These mod-
els feature lower MCMC autocorrelation, and thus required only two chains
Fig. 3. Mean curves for the supplemental data for a subset of discordance parameter (d)
values. The mean curve for the primary data is denoted by the solid line (i.e., d= 0).
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with 2000 iterations of burn-in, followed by 20,000 iterations for posterior
estimation. These choices reflect preliminary investigations to ensure accept-
able MCMC convergence and relatively small MC standard errors for the
intercept and functional effect coefficients. Estimation of the GMC model
took about 45 seconds, whereas estimation of each comparison model took
about 5 seconds.
To evaluate the three models, we calculated four criteria at each run:
mean error (ME), root-mean-square error (RMSE), mean pointwise credi-
ble interval width (CrIW), and mean pointwise coverage probability (CP).
Alternatively, we could calculate simultaneous confidence bands following
Krivobokova, Kneib and Claeskens (2010), Section 3. We define the four
criteria as
ME(d(m)) =N−1
N∑
i=1
[φˆ(ti|d
(m))− µ(ti|d
(m))],
RMSE(d(m)) =
{
N−1
N∑
i=1
[φˆ(ti|d
(m))− µ(ti|d
(m))]2
}1/2
,
CrIW(d(m)) =N−1
N∑
i=1
[φˆ0.975(ti|d
(m))− φˆ0.025(ti|d
(m))],
CP(d(m)) =N−1
N∑
i=1
I{µ(ti|d
(m)) ∈ [φˆ0.025(ti|d
(m)), φˆ0.975(ti|d
(m))]},
for m= 1, . . . ,M , where φˆ(t|d(m)) denotes the posterior mean estimate for
φ(t|d(m)), and φˆq(t|d
(m)) denotes the qth quantile posterior estimate of
φ(t|d(m)) in the mth run. We then compare the sampling average of each cri-
terion over theM simulated data set pairs as a function of d, the discordance
parameter. Specifically, we visually compare Loess estimates of each eval-
uation criteria as a function of the discordance parameter. One simulation
iteration takes about 60 seconds, which entails generating a pair of data sets,
fitting the three models, and then calculating and saving the evaluation crite-
ria, along with the sampled value of d in that run. We reduced overall compu-
tation time using the snowfall package for R to conduct the simulation runs
in parallel. A R program to implement this simulation is available through the
third author’s software page http://www.biostat.umn.edu/˜brad/software.
html.
The results of our simulation investigation are illustrated in Figure 4. Each
panel shows the Loess estimates of the sampling average of the corresponding
evaluation criteria as a function of d for three models: the GMC prior model
(solid), the conventional model fit to the primary data alone (dashed), and
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Fig. 4. Simulation assessment of the GMC prior spline model (solid) versus a conven-
tional spline model fit to the primary data alone (dashed) and to the data set obtained
by pooling the supplemental and primary data (dot-dashed). These methods are compared
on sampling averages of mean error (top left), root-mean-square error (top right), mean
credible interval width (bottom right) and mean pointwise coverage probability (bottom left)
as a function of d, the discordance parameter. All results are based on M = 2000 runs.
the conventional model fit to the pooled data (dot-dashed). As expected,
inferential properties for the GMC prior model reflect those for the pooled
approach under true concordance (i.e., d = 0) and approach primary data
alone for increasing degrees of discordance. The primary-alone approach
has the largest average CrIW and RMSE under true concordance, but its
properties do not deteriorate for increasing degrees of discordance (because
it does not acknowledge the supplemental data). By contrast, the pooling
approach has the smallest CrIW and RMSE under true concordance, but
its performance on all four evaluation criteria deteriorates substantially as
discordance increases.
The ME plot (top left panel) in Figure 4 demonstrates that the GMC
prior model has bias properties that interpolate the two conventional ap-
proaches for near concordance, but near d= 1 it learns to effectively ignore
the supplemental information. Furthermore, the RMSE (top right panel)
shows that the GMC prior model learns to borrow strongly from the supple-
mental information when the sources are commensurate (i.e., slight discor-
dance), achieving RMSE similar to that of the pooling approach. Similarly,
the CrIW plot (bottom right panel) shows for slight discordance that the
credible intervals from the GMC prior model are nearly as tight as those for
the pooling approach. Conversely, when the supplemental curve has greater
oscillation than the primary curve, the GMC prior approach has credible
interval width similar to those of the primary-alone approach. Last, the CP
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plot (bottom left panel) shows that the mean pointwise coverage probabili-
ties for the GMC prior model are similar to those of the conventional spline
model fit to the primary data alone.
3.3. Application: Liver imaging study. We now apply our GMC prior
model structure to estimate the temporal features of each perfusion char-
acteristic in cancerous liver tissue. Recall that similar information derived
from noncancerous tissue is potentially valuable supplemental information
because the shape of the average CTp curve in noncancerous regions may
provide relevant information about the shape of the corresponding average
CTp curve in cancerous regions. The data consist of 7 to 13 readings ac-
quired at times between 11 and 100 seconds after contrast injection in 0 to 2
cancerous and noncancerous regions of interest (ROIs) among 16 individuals.
For each perfusion characteristic, there are 687 total readings from fifteen
individuals who each contribute Ni = 11–13 readings in MT,i = 1–2 cancer-
ous and MN,i = 1–2 noncancerous ROIs, and one individual who contributes
7 readings in 1 noncancerous ROI.
Individual acquisition times ti,ℓ, ℓ = 1, . . . ,Ni, are necessarily identical
for all ROIs and all perfusion characteristics. Thus, we let yr,i,j,ℓ, for j =
1, . . . ,Mr,i, denote a reading at time ti,ℓ. We denote the average CTp curve
for a given perfusion characteristic in cancerous tissue and noncancerous
tissue by φT (t) and φN (t), respectively. We assume each individual’s CTp
curve deviates from the average CTp curve smoothly over time, and we
denote these deviation curves by ψr,i(t), r = T , N and i = 1, . . . ,16. We
then model
yr,i,j,ℓ∼N{φr(ti,ℓ) +ψr,i(ti,ℓ), σ
2
e,r}.(10)
We use the mLRTP model defined in (6) for φr and ψr,i, parametrized by
βr and αr,i, respectively. Therefore, the first derivative of the average CTp
curve is
φ′r(t;βr) = βr,1 +
K∑
k=2
sign(t− t˜k−1)3βr,k(t− t˜k−1)
2, r =N,T.(11)
To shrink the individual deviation curves ψr,i(t;αr,i) toward the average
CTp curve φr(t;βr), we assume αr,i,k ∼ N (0, σ
2
a,r,i), for k = 0, . . . ,K, r =
N,T and i= 1, . . . ,16.
For our conventional model, we use the prior specifications on βN and βT
described in (8), and specify vague N (0,104) priors for bN,0 and bT,0. For
the GMC prior model, we apply the prior developed in Section 3.1 for βT
given βN . That is, we specify a GMC prior for βT,(−0) = (βT,1, . . . ,βT,K)
given βN,(−0) = (βN,1, . . . ,βN,K) and an independent commensurate prior
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for bT,0 given bN,0. This choice enables differential borrowing from the non-
cancerous tissue data for the intercept versus the curve shape parameters,
and simultaneously enables borrowing similar amounts among curve shape
parameters. Thus, if the average CTp curve in noncancerous regions differs
from the average CTp curve in cancerous regions only for the intercept, the
model still permits borrowing for the CTp curve shape. Last, we place vague
U(0.01,100) priors on each of the standard deviation parameters (σe,r, σb,r,
σa,r,i).
We let t ∈ (0,1] by taking t=
t∗−t∗min
t∗max−t
∗
min
, where t∗ is the original timescale.
Preliminary analysis of the noncancerous regions was used to specify the
hyperparameters R = 500, sl = 0.01, su = 0.50, p0 = 0.10, a1 = 0.10 and
a2 = 0.90. To select a partition, we fit our conventional model (i.e., indepen-
dent spline models for the average CTp curve in each tissue type) for each
perfusion parameter using K = 5, 10, 15 and 25 with t˜ equally spaced over
[0,1], and using K = 5, 10 and 15 with t˜ placed at equally spaced quantiles
of the observed acquisition times. The model using K = 10 with quantile-
spaced knots resulted in low deviance and low DIC relative to models with
the other partitions for all three perfusion characteristics, so we chose to
conduct our analysis using this partition. We estimated the conventional
model using 40,000 posterior samples after 2000 burn-in samples from two
MCMC chains. We estimated the GMC model posterior using 200,000 pos-
terior samples after 20,000 burn-in samples from two MCMC chains; there
was greater autocorrelation for the basis coefficient parameters than the
conventional model.
Table 1 reports the posterior mean borrowing parameters (i.e., ιk’s) from
the GMC model for the three perfusion characteristics. Values near 1 in-
dicate strong borrowing for the corresponding basis parameter. The first
column reports the posterior mean for ι0, which corresponds to the inter-
cept. PS and BF show virtually zero borrowing for the intercept, whereas
BV shows little borrowing. The remaining columns illustrate borrowing for
the basis parameters that control the shape (and thus, first derivative) of the
CTp curve, which we have restricted to have similar magnitude by assuming
Table 1
Posterior borrowing parameter estimates (i.e., ιk’s). ι0 corresponds to the CTp curve
intercept, and the remaining ιk ’s correspond to CTp curve shape. Values near one
indicate strong borrowing
Perfusion characteristic ι0 ι1 ι2 ι3 ι4 ι5 ι6 ι7 ι8 ι9 ι10
PS 0.00 0.23 0.00 0.00 0.24 0.43 0.24 0.05 0.15 0.03 0.34
BV 0.20 0.92 0.95 0.92 0.82 0.86 0.90 0.82 0.88 0.96 0.96
BF 0.02 0.96 0.98 0.92 0.92 0.93 0.94 0.92 0.96 0.98 0.99
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Fig. 5. The first column displays posterior mean CTp curves from the conventional model
analysis for cancerous (solid black) and noncancerous regions (dotted grey), along with
95% pointwise CrIs. The second column displays the same results for the GMC model
analysis. The third column compares the posterior mean first derivative of the CTp curve
in cancerous tissue from the conventional model (solid black) and the GMC prior model
(dotted grey), along with 95% pointwise CrIs.
ιk|ν ∼ Bern(ν), for k = 1, . . . ,10, a priori. For PS, these parameters all have
posterior means less than 0.43, and many less than 0.25, which indicates
little borrowing for CTp curve shape. In contrast, these parameters all ex-
ceed 0.82 for BV, and 0.92 for BF. Thus, for BF and BV the GMC model
borrows substantially from the supplemental information in noncancerous
tissue for CTp curve shape in cancerous tissue.
The first row in Figure 5 indicates that both the shape and intercept of
the PS curve differ substantially by tissue type and that the results of the
conventional model analysis (first column) and the GMC prior model anal-
ysis (second column) are virtually indistinguishable. Consequently, the first
derivative of the CTp curve in cancerous tissue (third column) is estimated
with similar precision in either the conventional or GMC model analysis. In
fact, the GMC prior model results in 95% pointwise credible intervals (CrIs)
that are 4% wider on average than those of the conventional model analysis.
Regardless, the PS CTp curve in cancerous tissue has not stabilized after
95 seconds, so longer acquisition durations for PS appear necessary, which
is consistent with the findings by Ng et al. (2013).
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The second row in Figure 5 corresponds to BV. Here the GMC prior
model, relative to the conventional model, results in a noncancerous CTp
curve that is more similar for both the intercept and the shape to that of the
cancerous tissue CTp curve. Moreover, the GMC model gains precision over
the conventional model for the first derivative estimate of the cancerous
tissue CTp curve via borrowing from the noncancerous tissue CTp curve
shape. The average 95% pointwise CrIs for the GMC model are 18% tighter
than those of the conventional model. The third row corresponds to BF
and illustrates that the posterior CTp curve estimates are similar for the
two modeling approaches. However, the first derivative of the cancerous
tissue CTp curve is estimated more precisely for the GMC model than the
conventional model, resulting in 27% tighter 95% pointwise CrIs on average.
For both BF and BV, we can infer a shorter acquisition duration using the
GMC prior model than using the conventional model, although we did not
impose precise stability criteria here.
4. GMC priors in semiparametric survival analysis. We now describe
a flexible semiparametric survival model and then apply our GMC prior
technology to the colorectal cancer clinical trials data described in Section 1.
For simplicity, assume each observation consists of a possibly right-censored
time t ∈ (0,1], a binary event indicator c and a binary treatment indicator z.
4.1. Piecewise-exponential proportional hazards model. A flexible sur-
vival model commonly favored by Bayesians is the piecewise-exponential
proportional hazards model, which is constructed by partitioning the time
axis into K intervals t˜ = (0 = t˜0 < t˜1 < · · · < t˜K−1 < t˜K = 1) and assum-
ing the baseline hazard is constant in each interval [cf. Ibrahim, Chen and
Sinha (2001), Section 3.1]. Under this model, the likelihood for an observa-
tion (t, c, z) is given by h(t|z;γ, ρ)c exp{−
∫ t
0 h(s|z;γ, ρ)ds}, where
h(t|z;γ, ρ) = exp(γk + ρz) for t ∈ Ik = (t˜k−1, t˜k], k = 1, . . . ,K.(12)
Thus, h(t|z;γ, ρ) is assumed to be piecewise-constant, where γk denotes the
log-hazard in the kth interval of the time-axis partition t˜ for treatment
assignment z = 0, and ρ denotes the log-hazard ratio for treatment assign-
ment z = 1 relative to z = 0. Following Ibrahim, Chen and Sinha (2001),
we select K using a DIC comparison over a small set of partitions. To re-
sist overfitting, we specify a correlated prior process for π∗(γ). We focus on
the random-walk prior process for π∗(γ) introduced by Fahrmeir and Lang
(2001). Formally, we specify
π∗(γ1)≡N (γ1|0,10
4),
π∗(γk|γk−1, σγ)≡N (γk|γk−1, σ
2
γ) for k = 2, . . . ,K and(13)
π∗(σγ)≡ U(σγ |0.01,100).
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The prior process in (13) smooths adjacent γk’s toward each other by assum-
ing their first differences are exchangeable. We also assume ρ is independent
of γ a priori, and specify a vague N (0,104) prior. The model defined in (12)
is useful in the absence of supplemental data, and the parameter space can
be decomposed into separable subsets, γ characterizes the baseline hazard
and ρ characterizes the treatment effect.
4.2. Application: Colorectal cancer trials. Extending Hobbs, Carlin and
Sargent (2013), we apply our GMC prior model structure to supplement
the inference on the progression-free survival (PFS) curve among all three
regimens in the trial reported by Goldberg et al. (2004) using the historical
information on the IFL regimen from the trial reported by Saltz et al. (2000).
We use the piecewise-exponential proportional-hazards model to estimate
the PFS curves for the two trials from these data. During the first two years
of follow-up, the primary (Goldberg) data set contains 197 progression events
among 211 persons treated with IFL, 190 events among 216 persons treated
with FOLFOX, and 189 events among 206 persons treated with IROX. For
the primary data, we have two binary treatment indicators for assignment
to the FOLFOX (zF ) and IROX (zI) regimens, respectively, so following
(12) we model
h(t|z;γ,ρ) = exp(γk + ρF zF + ρIzI) for t ∈ (t˜k−1, t˜k],
where k = 1, . . . ,K. The supplemental (Saltz) data contain 172 progression
events during the first two years of follow-up among 224 persons treated with
IFL. The model for the supplemental data is defined analogously, though
zF = zI = 0 for all the supplemental observations. Therefore, the supple-
mental hazard model is completely parametrized by γ0, which, as required,
is analogous to γ.
We specify a GMC prior to flexibly borrow strength from the supple-
mental information on the IFL regimen. Namely, we specify the random-
walk prior process defined by (13) for π∗(γ0), and apply the GMC prior
structure on γ. In this setting, the prior specification follows as γ1|γ0,1, ι1 ∼
[N (γ1|0,10
4)]1−ι1 [N (γ1|γ0,1,R
−1
γ )]
ι1 , γk|γk−1, γ0,k, ιk, σγ ∼ [N (γk|γk−1,
σ2γ)]
1−ιk [N (γk|γ0,k,R
−1
γ )]
ιk , for k = 2, . . . ,K, and ιk|νγ ∼ Bern(νγ), for k =
1, . . . ,K, where Rγ is prespecified. Next, we place a B(a1, a2) prior on νγ ,
where a1 and a2 are also prespecified. Last, we place vague U(0.01,100)
priors on each of the standard deviation parameters (i.e., σγ and σγ0) and
vague N (0,104) priors on the treatment effect parameters (i.e., ρF and ρI).
We transformed the timescale so that t ∈ (0,1], then selected Rγ = 10,000
and specified a vague B(0.10,0.90) prior for νγ , which represents a vague,
yet skeptical prior opinion about the relevance of the supplemental data. For
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estimation, we used 200,000 posterior samples for estimation after 50,000 it-
erations of burn-in from two MCMC chains. For comparison, we also fit con-
ventional piecewise-exponential proportional hazards models with the same
time-axis partition and random-walk prior process to the primary (Gold-
berg) data alone, supplemental (Saltz) data alone, and the data set obtained
by naively pooling the two sources of information. To estimate these conven-
tional models, we used 20,000 posterior estimation draws after 2000 burn-in
draws from two MCMC chains, again the shorter chain length justified by
faster convergence and lower post-convergence autocorrelations.
We begin with a comparison of the estimated PFS curves for the IFL
regimen from the four analyses. The left panel in Figure 6 indicates that the
estimated PFS curve from the Goldberg data (solid, with shaded grey 95%
pointwise CrIs) overlaps substantially with the PFS curve estimated from
the Saltz data (dashed, with dotted 95% pointwise CrIs), suggesting the
Saltz data provide relevant information. The middle panel in Figure 6 illus-
trates that the GMC analysis (solid, with shaded grey 95% pointwise CrIs)
results in a PFS estimate nearly indistinguishable from that of the conven-
tional analysis of the pooled data set (dashed, with dotted 95% pointwise
CrIs), though shifted very slightly toward the primary information. The
Fig. 6. The left panel displays the posterior mean PFS curve for the IFL regimen along
with 95% pointwise CrIs from the conventional piecewise-constant-hazard analysis of the
primary (Goldberg) data alone and the supplemental (Saltz) data alone. The middle panel
displays the same results from the GMC prior model analysis and the conventional model
analysis of the dataset obtained by pooling the two sources of information. The third panel
displays a posterior histogram for νγ , which controls borrowing for the baseline hazard
among trials. For reference, the prior assigned to νγ is also displayed (grey line).
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Table 2
Hazard-ratio estimates for the FOLFOX and IROX regimens relative to the IFL regimen,
and estimates of median days to disease progression for each treatment regimen from the
four analyses of the Goldberg data and Saltz data
Drug regimen IFL FOLFOX IROX
Analysis Hazard ratios ( 95% CrIs)
Goldberg alone – 0.70 (0.57, 0.86) 0.92 (0.75, 1.12)
Pooled analysis – 0.66 (0.56, 0.79) 0.87 (0.73, 1.04)
GMC prior analysis – 0.66 (0.56, 0.79) 0.87 (0.73, 1.04)
Median days to disease progression ( 95% CrIs)
Saltz alone 200 (168, 236) – –
Goldberg alone 205 (182, 227) 262 (235, 293) 217 (194, 242)
Pooled analysis 200 (182, 217) 263 (245, 286) 221 (201, 240)
GMC prior analysis 200 (184, 216) 265 (245, 286) 221 (203, 240)
GMC prior model achieved a PFS curve estimate with noticeably greater
precision than that of the conventional analysis that ignores the supplemen-
tal data without requiring bold a priori assumptions regarding the relevance
of the Saltz data. Finally, the rightmost panel in Figure 6 displays a posterior
histogram of νγ that has much of its mass shifted toward one. In fact, the
ιk’s had posterior means of at least 0.87, with an average of 0.94, indicating
that the GMC prior model has learned that the supplemental FOLFOX data
from the Saltz trial are indeed relevant.
Turning to the comparative effectiveness of three regimens, Table 2 shows
that the hazard ratios (95% CrIs) from the GMC prior model analysis for
FOLFOX and IROX versus IFL are 0.66 (0.56,0.79) and 0.87 (0.73,1.04), re-
spectively. The hazard ratios from the conventional analysis of the Goldberg
data alone are slightly larger with notably wider CrI widths, 0.70 (0.57,0.86)
for FOLFOX and 0.92 (0.75,1.12) for IROX. By contrast, the hazard-ratio
estimates and CrI widths from the conventional analysis of the pooled data
set are indistinguishable from the GMC prior model analysis. Table 2 also
contains the posterior estimates from each analysis of median PFS for the
IFL, FOLFOX and IROX regimens. The conventional analysis of the Saltz
data alone estimates median PFS in the IFL regimen to be 200 (168, 236)
days, broadly similar to the estimate of 205 (182, 227) days provided by the
conventional analysis of the Goldberg data alone. The estimates of median
days to disease progression for each regimen from the pooled analysis of these
data are also nearly identical to the estimates from the GMC prior analysis,
namely, 200, 265 and 221 days for the IFL, FOLFOX and IROX regimens,
respectively. The estimates from the GMC prior model are consistent with
the results reported by Goldberg et al. (2004), who found FOLFOX to be
the superior regimen, and significantly better than IFL. In addition, the
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GMC prior analysis yields stronger evidence that IROX may be better than
IFL for PFS, though the difference remains statistically insignificant.
5. Discussion and future work. Our proposed methods for prior specifi-
cation in functional and survival data models with penalized splines facilitate
data-dependent borrowing that is robust to biased estimation of primary ef-
fects when conflict among information sources occurs. The simulation study
illustrates the beneficial flexible borrowing properties the proposed methods
offer. The application in perfusion CT illustrates potential gains in CTp
curve estimation from using supplemental data collected concurrently. By
contrast, the colorectal cancer application illustrates the use of these meth-
ods for semiparametric survival modeling to flexibly borrow from supple-
mental data on a control therapy collected in a previous trial. A hierarchical
model with the proposed structure allows the degree of borrowing to be
estimated differentially for each feature (e.g., CTp curve intercept versus
shape). The amount of strength being borrowed between sources reflects the
evidence of commensurability for that feature. When substantial evidence
indicates that sources differ for a feature, the proposed method will learn to
effectively ignore the supplemental data for that feature, yet possibly still
borrow strength for another feature. For minor discordance or concordance,
the proposed method also facilitates partial (rather than full) pooling of
information from the supplemental source, hence a modest yet justifiable
gain in efficiency. Our general modeling strategy enables data-driven esti-
mation of heterogeneity among information sources for complex functional
relationships, and thus provides a sensible and justifiable synthesis of clinical
information.
In future work, we plan to extend the commensurate prior approach to
settings that have multiple supplemental sources of information. This setting
substantially complicates the construction of a hierarchical model that facil-
itates flexible borrowing for each supplemental source. Ideally, the method
will facilitate data-dependent differential borrowing from various sources,
learning from which to borrow and which to ignore as primary data accu-
mulate. We also hope to develop concise, interpretable summaries that quan-
tify the amount of strength being borrowed from each information source,
thereby allowing the use of these models in an adaptive trial [see Hobbs, Car-
lin and Sargent (2013)]. We will also consider using posterior summaries of ν
in (5) to determine whether the curves are commensurate among information
sources, for example, by assessing Pr(ν > 0.80|D,D0)> 0.90. Furthermore,
we are currently studying the properties of the piecewise-exponential model
used in the colorectal cancer application, which relies on a simple, yet flexible
piecewise-constant assumption for the baseline hazard. We are developing
extensions that use a piecewise-linear model for the baseline hazard function,
relax the proportional hazards assumption, and allow functional covariate
effects with shape constraints (e.g., monotonicity).
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